Technology Commercialization Office

Showing 3 result(s) for "Biologics"



Engineered calmodulin-based therapeutics for the treatment of cardiovascular diseases.

A novel plasmid addiction system for cost-effective end-product generation.

Identification and use of novel adipokines for reduction of visceral fat using thermogenesis.